Outliers? [BE/BA News]

posted by mittyri – Russia, 2022-12-02 23:52 (532 d 08:14 ago) – Posting: # 23382
Views: 6,056

Hi Helmut,

❝ Three options.

  1. Hire a consultant with a SAS license.

  2. AFAIK, the FDA recalculates all studies. Cross fingers.

  3. Wait till someone publishes a paper about cross-validation. ;-)

I'll cross fingers to have that omitted from the final guidance (even if I do not plan to submit to FDA anything:-D; FDA guidelines are getting used to penetrate across the world).

❝ As an aside:

How to assess ‘outliers’ in RSABE?

the only one method I can recall is described by Mr.Schall with coauthors
But I know that your question is not trivial and deeper than that.

PS: what is wrong with the format of cited list?

Kind regards,

Complete thread:

UA Flag
 Admin contact
23,029 posts in 4,834 threads, 1,641 registered users;
32 visitors (0 registered, 32 guests [including 8 identified bots]).
Forum time: 09:07 CEST (Europe/Vienna)

The most erroneous stories are those we think we know best–
and therefore never scrutinize or question.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz